Apeloa Pharmaceutical Co Ltd Class A 000739
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥15.78
- Day Range
- ¥16.15–17.33
- 52-Week Range
- ¥10.66–19.70
- Bid/Ask
- ¥17.24 / ¥17.25
- Market Cap
- ¥20.16 Bil
- Volume/Avg
- 22.8 Mil / 8.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 18.32
- Price/Sales
- 1.54
- Dividend Yield (Trailing)
- 2.01%
- Dividend Yield (Forward)
- 2.01%
- Total Yield
- 2.01%
Company Profile
Apeloa Pharmaceutical Co Ltd is a pharmaceutical company. It is engaged in research and development, manufacturing and marketing of APIs formulations and veterinary drugs. It offers products including Ofloxacin, Levofloxacin Hydrochloride, Marbofloxacin, and others.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 7,208
- Website
- https://www.apeloa.com
Comparables
Valuation
|
Metric
|
000739
|
600216
|
688553
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.32 | 64.26 | 53.62 |
Price/Book Value | 2.91 | 1.56 | 1.31 |
Price/Sales | 1.54 | 1.85 | 4.86 |
Price/Cash Flow | 9.69 | 14.96 | 27.30 |
Price/Earnings
000739
600216
688553
Financial Strength
|
Metric
|
000739
|
600216
|
688553
|
|---|---|---|---|
Quick Ratio | 0.97 | 1.68 | 2.65 |
Current Ratio | 1.30 | 2.66 | 2.93 |
Interest Coverage | 35.39 | 15.43 | 12.08 |
Quick Ratio
000739
600216
688553
Profitability
|
Metric
|
000739
|
600216
|
688553
|
|---|---|---|---|
Return on Assets (Normalized) | 7.96% | 1.81% | 1.73% |
Return on Equity (Normalized) | 16.93% | 2.37% | 2.13% |
Return on Invested Capital (Normalized) | 13.55% | 2.20% | 1.32% |
Return on Assets
000739
600216
688553
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Zckrcsjzy | Wmxfr | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Czztgggpg | Ynqvl | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Jcsgtqv | Grgwp | $48.4 Bil | |||
| Viatris Inc
VTRS
| Fsgmhttd | Kpf | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Kqzcmwv | Vpwl | $13.5 Bil | |||
| Catalent Inc
CTLT
| Lfnfmllm | Cxgbhf | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Pjksfjc | Jxnlfzj | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Vlxblvjt | Dvrx | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gfjgxnnm | Xtkwp | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Lwgpyjbp | Bpscn | $2.3 Bil |
United States